Six years’ experience with LipidSeq: clinical and research learnings from a hybrid, targeted sequencing panel for dyslipidemias

BACKGROUND: In 2013, our laboratory designed a targeted sequencing panel, “LipidSeq”, to study the genetic determinants of dyslipidemia and metabolic disorders. Over the last 6 years, we have analyzed 3262 patient samples obtained from our own Lipid Genetics Clinic and international colleagues. Here...

Descripción completa

Detalles Bibliográficos
Autores principales: Dron, Jacqueline S., Wang, Jian, McIntyre, Adam D., Iacocca, Michael A., Robinson, John F., Ban, Matthew R., Cao, Henian, Hegele, Robert A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011550/
https://www.ncbi.nlm.nih.gov/pubmed/32041611
http://dx.doi.org/10.1186/s12920-020-0669-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011550/
https://www.ncbi.nlm.nih.gov/pubmed/32041611
http://dx.doi.org/10.1186/s12920-020-0669-2

Ejemplares similares